GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Days Sales Outstanding

Dr Lalchandani Labs (BOM:541299) Days Sales Outstanding : 358.80 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Days Sales Outstanding?

Dr Lalchandani Labs's average Accounts Receivable for the six months ended in Sep. 2023 was ₹53.60 Mil. Dr Lalchandani Labs's Revenue for the six months ended in Sep. 2023 was ₹27.26 Mil. Hence, Dr Lalchandani Labs's Days Sales Outstanding for the six months ended in Sep. 2023 was 358.80.

The historical rank and industry rank for Dr Lalchandani Labs's Days Sales Outstanding or its related term are showing as below:

BOM:541299' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.21   Med: 108.8   Max: 338.79
Current: 338.79

During the past 11 years, Dr Lalchandani Labs's highest Days Sales Outstanding was 338.79. The lowest was 20.21. And the median was 108.80.

BOM:541299's Days Sales Outstanding is ranked worse than
93.64% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs BOM:541299: 338.79

Dr Lalchandani Labs's Days Sales Outstanding increased from Sep. 2022 (350.07) to Sep. 2023 (358.80).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Dr Lalchandani Labs Days Sales Outstanding Historical Data

The historical data trend for Dr Lalchandani Labs's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Days Sales Outstanding Chart

Dr Lalchandani Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102.96 154.12 136.38 132.62 332.44

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.31 243.68 350.07 314.94 358.80

Competitive Comparison of Dr Lalchandani Labs's Days Sales Outstanding

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Days Sales Outstanding falls into.



Dr Lalchandani Labs Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dr Lalchandani Labs's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (42.151 + 49.661) / 2 ) / 50.402*365
=45.906 / 50.402*365
=332.44

Dr Lalchandani Labs's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (49.661 + 57.53) / 2 ) / 27.261*365 / 2
=53.5955 / 27.261*365 / 2
=358.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs  (BOM:541299) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Dr Lalchandani Labs Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines